CLENZIDERM NORMAL TO OILY SKIN

Product NDC: 62032-511
11-digit product format: 620320511
Labeler code: 62032
Product ID: 62032-511_c048c2d1-4ebd-49dd-a8e4-0c374cd20c1e
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID AND BENZOYL PEROXIDE
Dosage form: KIT
Labeler: OMP, INC.
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-01-01
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62032-511		I	Inactivated by FDA		2026-10-05
excluded package	package	62032-511	62032-511-02	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-511-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-511-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-511-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-511-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-511-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-511-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-511-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-511-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-511-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-511-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-511-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-511-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62032-511-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62032-511-02	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62032-511-02	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62032-511-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62032-511-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62032-511-02	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62032-511-02	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62032-511-02	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62032-511-02	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62032-511-02	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-511-02	2019-11-13	C162847	48780-1	97449f38-c3d7-f6ea-e053-dbdaa90aa703	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-110-60	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	118 mL in 1 BOTTLE, PLASTIC	LIQUID	118 mL	20 mg in 1mL	1
62032-111-60	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	118 mL in 1 BOTTLE, PLASTIC	LIQUID	118 mL	20 mg in 1mL	1
62032-113-65	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	47 mL in 1 BOTTLE, PLASTIC	LOTION	47 mL	50 mg in 1mL	1
62032-511-02	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	1 in 1 CARTON	KIT	1		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BENZOYL PEROXIDE	ACTIVE INGREDIENT	W9WZN9A0GM	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
BENZOYL PEROXIDE	ACTIVE MOIETY	W9WZN9A0GM	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL	INACTIVE INGREDIENT	KD6TZ2QICH	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
BENZYL BENZOATE	INACTIVE INGREDIENT	N863NB338G	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
CETYL HYDROXYETHYLCELLULOSE (350000 MW)	INACTIVE INGREDIENT	T7SWE4S2TT	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
COCAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	5OCF3O11KX	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
DICAPRYLYL ETHER	INACTIVE INGREDIENT	77JZM5516Z	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
DIETHYLENE GLYCOL MONOETHYL ETHER	INACTIVE INGREDIENT	A1A1I8X02B	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
DIMETHYL ISOSORBIDE	INACTIVE INGREDIENT	SA6A6V432S	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
EXT. D&C VIOLET NO. 2	INACTIVE INGREDIENT	G5UX3K0728	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
MENTHYL LACTATE, (-)-	INACTIVE INGREDIENT	2BF9E65L7I	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
SODIUM LAURETH SULFATE	INACTIVE INGREDIENT	BPV390UAP0	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-511	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]	1	Legacy NDC, 4 package rows	20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
106309	benzoyl peroxide 5 % Topical Lotion	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1236624	Clenziderm Lotion 5 % Topical Lotion	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235205	CLENZIderm M.D. 2 % Medicated Liquid Soap	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235208	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
562600	salicylic acid 2 % Medicated Liquid Soap	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
251577	salicylic acid 2 % Topical Solution	PSN	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1236624	benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]	SBD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235205	salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm]	SBD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235208	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
106309	benzoyl peroxide 50 MG/ML Topical Lotion	SCD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
562600	salicylic acid 20 MG/ML Medicated Liquid Soap	SCD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
251577	salicylic acid 20 MG/ML Topical Solution	SCD	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
106309	benzoyl peroxide 5 % Topical Lotion	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235205	Clenziderm 20 MG/ML Medicated Liquid Soap	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235208	Clenziderm 20 MG/ML Topical Solution	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1236624	Clenziderm Lotion 5 % Topical Lotion	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1236624	Clenziderm Lotion 50 MG/ML Topical Lotion	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235205	Clenziderm M.D. 2 % Daily Care Cleanser	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
1235208	Clenziderm M.D. 2 % Pore Therapy	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
562600	salicylic acid 2 % Facial Cleanser Toner	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
562600	salicylic acid 2 % Facial Scrub	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
562600	salicylic acid 2 % Medicated Liquid Soap	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1
251577	salicylic acid 2 % Topical Solution	SY	934ec314-1ab7-45ee-a2fe-8bff3ff981b6	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
62032-110-60	62032011060	118 mL in 1 BOTTLE, PLASTIC	118 ml	Historical
62032-111-60	62032011160	118 mL in 1 BOTTLE, PLASTIC	118 ml	Historical
62032-113-65	62032011365	47 mL in 1 BOTTLE, PLASTIC	47 ml	Historical
62032-511-02	62032051102	1 in 1 CARTON		Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	OMP, INC. \| PURETEK CORPORATION \| Ei INC.	2012-05-10	HUMAN OTC DRUG LABEL	1